h1

h2

h3

h4

h5
h6
http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png

Efficacy and safety of bosutinib in patients treated with prior imatinib and/or dasatinib and/or nilotinib: Subgroup analyses from the phase 4 BYOND study

; ; ; ; ; ; ; ; ; ; ; ;

In
Leukemia research 139, Seiten/Artikel-Nr.:107481

ImpressumAmsterdam [u.a.] : Elsevier Science

Umfang[1]-7

ISSN1873-5835

Online
DOI: 10.1016/j.leukres.2024.107481


Einrichtungen

  1. Klinik und Lehrstuhl für Innere Medizin (mit dem Schwerpunkt Onkologie und Hämatologie) (531040-2)



Dokumenttyp
Journal Article

Format
online, print

Sprache
English

Anmerkung
Peer reviewed article

Externe Identnummern
SCOPUS: SCOPUS:2-s2.0-85187922203
WOS Core Collection: WOS:001210067000001
PubMed: pmid:38484432
OpenAlex: W4392663444

Interne Identnummern
RWTH-CONV-254013
Datensatz-ID: 1007652

Beteiligte Länder
France, Germany, Italy, Spain, UK, USA

Lizenzstatus der Zeitschrift

 GO

Medline ; OpenAccess ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Life Sciences ; Ebsco Academic Search ; Essential Science Indicators ; Free to read ; IF < 5 ; JCR ; NationallizenzNationallizenz ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Articles
Faculty of Medicine (Fac.10)
Public records
531040\-2
Publications database
 Record created 2025-03-18, last modified 2026-09-14
Similar records



Rate this document:

Rate this document:
1
2
3
4
5
 
(Not yet reviewed)